Loading
Many cancer lab results cannot be reproduced, and trials built on them fail. Fund an independent institute that re-runs important experiments before anyone spends millions on humans.
The Reproducibility Project: Cancer Biology found that most high-profile preclinical results replicated only partially or not at all. Trials and companies are built on unreplicated findings. The proposal is a funded, independent replication institute with standing capacity in the common cancer model systems, which re-tests findings prioritised by their influence on planned trials or investments, publishes all results, and issues a replication grade that funders, investors and ethics committees can require before first-in-human studies.
Shares Patient-derived xenografts, Preclinical results do not reproduce, The valley of death between lab and product.
Shares Patient-derived xenografts, Patient-derived organoids.
Shares Patient-derived xenografts, Preclinical results do not reproduce, Patient-derived organoids, The valley of death between lab and product.
Shares Patient-derived xenografts, Preclinical results do not reproduce, Patient-derived organoids, The valley of death between lab and product.
Shares Patient-derived xenografts, Preclinical results do not reproduce, Patient-derived organoids.
Shares Patient-derived xenografts, Patient-derived organoids.
Shares Patient-derived xenografts, Preclinical results do not reproduce.
Shares Preclinical results do not reproduce, Patient-derived organoids, The valley of death between lab and product.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/